Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy

Immunotherapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer Following Chemoradiation Therapy

Speaker
Roy Decker, MD/PhD.
Professor of Therapeutic Radiology; Disease Aligned Research Team Leader, Therapeutic Radiology, Yale Cancer Center; Director, Residency Training Program; Director, Thoracic/Stereotactic Body Radiotherapy Program; Vice Chair for Clinical Research
Yale School of Medicine